Skip to main content

Urcuyo Delgado, Gabriela

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Urcuyo Delgado, Gabriela

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The donation will enable further characterisation of patients with this rare disease, the identification of new biomarkers and the exploration of innovative therapies.

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Related professionals

Idoia Bolinaga Ayala

Idoia Bolinaga Ayala

Predoctoral researcher
Protein kinases in cancer research
Read more
Rodrigo Maluje Juri

Rodrigo Maluje Juri

Predoctoral researcher
Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Marta Antonio Martín

Marta Antonio Martín

Predoctoral researcher
Cardiovascular Diseases
Read more
Marina Llanas Martinez

Marina Llanas Martinez

Predoctoral researcher
Molecular Imaging and Therapy
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.